December 2005

|
Volume 17 Issue 12
Percutaneous transluminal coronary angioplasty (PTCA) may be an effective treatment in selected patients with left ventricular dysfunction, but acute and long-term mortality rates are higher than in patients with normal left ventricular function.1–5…
Intracoronary radiation therapy (IRT) for in-stent restenosis (ISR) in native coronary arteries and saphenous vein grafts (SVG) has substantially reduced the rate of recurrent restenosis compared with conventional percutaneous coronary intervention (…
Since the introduction of coronary stenting to interventional cardiology in 1989, improvements in stent implantation techniques and antiplatelet drug therapy have dramatically improved the short-term and long-term outcomes of percutaneous interventio…
While the approach to identifying and treating a high-grade, symptomatic and ischemia-producing coronary stenosis is readily apparent, the optimal treatment of lesions without these characteristics is less established. The uncertainty is because plaq…
Background. A number of studies have examined the environmental and genetic basis contributing to the pathogenesis of various disease states. This has been studied in monozygotic twins and recently published. Recent reports have examined disease prev…
The Bentall procedure for aortic root and valve replacement with coronary reimplantation was initially described in 1968.1 This procedure is considered the “gold standard” for treatment of combined valve and ascending aortic pathology. The procedure…
Previous studies support the concept that atherosclerosis is an inflammatory disease.1,2 Inflammation plays an important role not only in the development, but also in the acute complications of atherosclerotic plaques.3 The detection of plaque temper…
Although the backup force of a guiding catheter is important for successful percutaneous coronary intervention (PCI), no theory has been proposed thus far regarding the factors involved in its generation. Thus far, our understanding stems only from t…
Reports to the Center for Devices and Radiological Health (CDRH) of the FDA regarding serious injuries and deaths associated with the use of vascular hemostasis devices1 provided the impetus for this study. These devices are used primarily to stop bl…